| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |